Moderna
MRNA
$129.06
Share price
0.58%
Change (1 day)
-0.92%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Operating Margin for Moderna (MRNA)
Operating Margin as of May 2024 (TTM): 5.44%
According to Moderna 's latest financial reports and stock price the company's current Operating Margin is 5.44%. At the end of 2022 the company had an Operating Margin of 49.71%.
Operating Margin history for Moderna from 2018 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 49.71% | -33.64% |
| 2021 | 74.90% | -127.62% |
| 2020 | -271.24% | -74.69% |
| 2019 | -1,071.52% | 241.5% |
| 2018 | -313.77% | 116.92% |
| 2017 | -144.65% | -31.74% |
| 2016 | -211.91% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 320.59% | 🇺🇸 USA |
 Novartis NVS | 17.27% | 217.46% | 🇨🇭 Switzerland |
 Merck MRK | 27.73% | 409.74% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | -119.48% | -2,296.32% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | -61.01% | -1,221.45% | 🇺🇸 USA |
 Athersys ATHX | -1,576.98% | -29,088.60% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -108.63% | -2,096.88% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | -71.00% | -1,405.15% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.